Fresh Rounds

Auron Therapeutics, Inc. funding

Auron Therapeutics, Inc., a biotechnology company based in Wellesley, MA, filed a Form D with the SEC on August 13, 2026 and reported $7.1M raised of a $12M offering.

Amount raised$7.1M
Offering size$12M
Filed with the SECAugust 13, 2026
First saleAugust 10, 2026
IndustryBiotechnology
SecuritiesDebt
LocationWellesley, MA
FoundedMore than 5 years ago
Entity typeCorporation
Investors so far14
Minimum investment—
Revenue rangeDecline to Disclose

Other health care rounds in Massachusetts